Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Sankyo Pharma and Cygnus announced that the GlucoWatch® G2™ Biographer is now available. He GlucoWatch G2 Biographer is the second-generation model of the GlucoWatch® Biographer, the first and only monitoring system that provides glucose readings continuously, automatically and non-invasively.
“The GlucoWatch G2 Biographer represents a significant technological advancement that provides even greater convenience and efficiency to physicians and patients with diabetes, helping them to make better-informed decisions on how to manage the disease,” said Joseph P. Pieroni, President of Sankyo Pharma.
As an added value to customers, Sankyo will give a rebate of up to $200 through the end of this year to purchasers of the Biographer who meet certain eligibility requirements.
The GlucoWatch G2 Biographer has a number of enhanced features over the first-generation GlucoWatch Biographer include the following:
It measures and displays glucose levels automatically and stores readings up to every 10 minutes – twice as frequently as the first-generation product.
It provides automatic non-invasive readings for up to 13 hours a day – up from 12 hours in the first version.
It also creates an “electronic diary,” storing up to 8,500 glucose values – compared to 4,000 in the first version – that can be reviewed at the touch of a button, or uploaded into a software program, helping detect trends and track patterns in glucose levels.
Additional information about the GlucoWatch G2 Biographer can be obtained by calling the toll-free number 1-866-GLWATCH or by visiting https://www.glucowatch.com.